The big lab models are academically interesting but business wise they seem toast long term. There’s no way for these model companies to compete when the models are becoming a pure commodity and others offering options that are orders of magnitude cheaper.
It’s not that the big labs couldn’t theoretically just also put out 100x cheaper options but their business model requires them to generate huge revenues from higher priced tokens or they’ll implode.
It’s not that the big labs couldn’t theoretically just also put out 100x cheaper options but their business model requires them to generate huge revenues from higher priced tokens or they’ll implode.